Effective sustainability strategies in pharma supply chains reduce rework and overage. Three leakage points offer the most practical starting point for rooting out waste.
- Regulatory Readiness In Clinical Supply: Building A Culture Of Compliance, Part 1
- Optimizing Clinical Trial Supply Chains For Epidemic Response
- The High Cost Of Zero Waste: Protecting Patients In Clinical Supply
- From Crisis Response To Repeatable Resilience In Clinical Supply
- Transitioning Into A Clinical Trial Supply Chain Study Lead Role
- U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact
- Beyond The AI Hype: Prompt Engineering In Clinical Trial Supply
- Active Versus Passive Shipping Solutions For Clinical Shipments
ON-DEMAND WEBINARS
Gain insight into how a patient-centric approach to supply chain innovation in early phase development can accelerate your advanced therapy clinical trial programs.
Achieving supply chain resilience is crucial, and flexible distribution strategies and ready-to-use depot and logistics networks are instrumental in establishing limitless flexibility and expertise capable of identifying possible risks.
Individual data points over time can provide precise drug dosing histories that enable better understanding of protocol adherence, safety, efficacy, PK/PD and a drug’s exposure-response relationship.
In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Pharmaceutical packaging pharmacy iStock-840095386]( "3 IRT Tactics Being Used To Streamline Supply Logistics")
3 IRT Tactics Being Used To Streamline Supply LogisticsShipping and storing leading-edge therapeutics require complex logistics, but enhanced automation and process simplification ensure that sites and patients have the drugs they need when they need them.
-
![GettyImages-1163506017 labeling]( "IMP Labeling: EU CTR Transition Considerations")
IMP Labeling: EU CTR Transition ConsiderationsReview current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.
-
![iStock-1276580570-cryopreservation]( "Key Considerations For Labeling Your Cell Or Gene Therapy")
Key Considerations For Labeling Your Cell Or Gene TherapyAs sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.
-
![Singota]( "Faster From Formulation To Fill/Finish")
Faster From Formulation To Fill/FinishOptimize your speed to clinic by securing a development and aseptic fill/finish partner to support your applications with the right manufacturing equipment, communications, and SOPs.
-
![GettyImages-1404941712-Capsules_Blister_Packaging]( "Gain Confidence In Clinical Trial Outcomes")
Gain Confidence In Clinical Trial OutcomesDelve into the ways that smart packaging integrations within clinical trial strategies can improve adherence to dosing protocols and provide a comprehensive understanding of a patient’s exposure.
-
![Getty-1652511983-supply-chain-management]( "A Custom IRT System Facilitates Precision Medicine Studies")
A Custom IRT System Facilitates Precision Medicine StudiesAs the industry continues to embrace personalized medicine, the ability to implement and support an atypical supply chain is crucial.
-
![GettyImages-1214112149-lab-team-collaboration-research]( "Creating Accurate, Efficient, And Effective CDMO Project Proposals")
Creating Accurate, Efficient, And Effective CDMO Project ProposalsTo receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.
-
![Scientist syringe vaccine GettyImages-1351831059]( "Overcome The Supply Chain Complexities Of Vaccine Development")
Overcome The Supply Chain Complexities Of Vaccine DevelopmentExplore the industry impact of rapidly evolving vaccinology, the power of next-gen science and technology, and how finding the right supply chain partner has never been more essential.
-
![Vials pharma manufacturing GettyImages-618518692]( "Planning Your Packaging For A Seamless Transition From Clinic To Launch")
Planning Your Packaging For A Seamless Transition From Clinic To LaunchExplore how clinical and commercial teams should work together for clinical supply packaging, how the COVID-19 pandemic has changed things, and what to consider when looking for a packaging partner.
-
![iStock-1219082584-delivery-direct-logistics]( "How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution")
How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End SolutionAnalyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
